Key Takeaways BPC-157 is a 15-amino-acid peptide derived from a human gastric protein
Clinical Benefits: Supports red blood cell formation and helps prevent megaloblastic anaemia Essential for neurological function and nerve tissue health Plays a key role in DNA synthesis and cell metabolism Supports cognitive function, concentration, and mood regulation Assists in the conversion of homocysteine, supporting cardiovascular health Helps address fatigue and weakness associated with B12 deficiency For patients presenting with deficiency, a loading protocol is typically recommended: weekly injections for three weeks, followed by monthly injections for three months, then a maintenance injection every three months
Neuroprotective & CNS Effects Preliminary evidence from animal models suggests that BPC-157 may support neurological recovery following stroke or spinal injury
The interest has helped fuel a grey market where consumers seek access to research-grade injections, including experimental weight-loss therapies such as retatrutide
Standard acetate forms of BPC-157 suffered approximately 97% degradation in acidic gastric conditions despite the peptides inherent stability
Instantly switch between mcg, mg, and g without re-entering data